Detailed information for compound 1805261

Basic information

Technical information
  • TDR Targets ID: 1805261
  • Name: dimethyl 2,6-dimethyl-4-propyl-1,4-dihydropyr idine-3,5-dicarboxylate
  • MW: 267.321 | Formula: C14H21NO4
  • H donors: 1 H acceptors: 2 LogP: 2.51 Rotable bonds: 6
    Rule of 5 violations (Lipinski): 1
  • SMILES: CCCC1C(=C(C)NC(=C1C(=O)OC)C)C(=O)OC
  • InChi: 1S/C14H21NO4/c1-6-7-10-11(13(16)18-4)8(2)15-9(3)12(10)14(17)19-5/h10,15H,6-7H2,1-5H3
  • InChiKey: XUVYCXPLRPBFFP-UHFFFAOYSA-N  


Substructure search Similarity search

Network

Hover on a compound node to display the structore

Synonyms

  • 2,6-dimethyl-4-propyl-1,4-dihydropyridine-3,5-dicarboxylic acid dimethyl ester

Targets

Known targets for this compound

No curated genes were found associated with this compound

Predicted pathogen targets for this compound

By orthology
No druggable targets predicted by orthology data
By sequence similarity to non orthologous known druggable targets
No druggable targets predicted by sequence similarity
Obtained from network model

Ranking Plot

Putative Targets List

Species Potential target Raw Global Species
Toxoplasma gondii hypothetical protein 0.0116 0.0515 1
Trichomonas vaginalis rod cGMP-specific 3,5-cyclic phosphodiesterase, putative 0.0161 0.0839 0.233
Mycobacterium ulcerans putative regulatory protein 0.0116 0.0515 0.5
Schistosoma mansoni camp/cgmp cyclic nucleotide phosphodiesterase 0.0161 0.0839 0.233
Toxoplasma gondii hypothetical protein 0.0116 0.0515 1
Trichomonas vaginalis conserved hypothetical protein 0.0116 0.0515 0.1431
Onchocerca volvulus 0.0543 0.36 0.5
Echinococcus multilocularis dual 3',5' cyclic AMP and GMP phosphodiesterase 0.0161 0.0839 0.0839
Echinococcus granulosus cAMP and cAMP inhibited cGMP 3'5' cyclic 0.1428 1 1
Mycobacterium leprae conserved hypothetical protein 0.0116 0.0515 0.5
Trichomonas vaginalis cGMP-dependent 3,5-cyclic phosphodiesterase, putative 0.0161 0.0839 0.233
Giardia lamblia CAMP-specific 3,5-cyclic phosphodiesterase 4B 0.0045 0 0.5
Trichomonas vaginalis rod cGMP-specific 3,5-cyclic phosphodiesterase, putative 0.0161 0.0839 0.233
Trichomonas vaginalis cGMP-specific 3,5-cyclic phosphodiesterase, putative 0.0161 0.0839 0.233
Trypanosoma cruzi cAMP specific phosphodiesterase, putative 0.0161 0.0839 1
Trypanosoma cruzi cAMP specific phosphodiesterase, putative 0.0161 0.0839 1
Trichomonas vaginalis calcium/calmodulin-dependent 3,5-cyclic nucleotide phosphodiesterase, putative 0.0161 0.0839 0.233
Plasmodium falciparum GAF domain-related protein, putative 0.0116 0.0515 1
Plasmodium vivax hypothetical protein, conserved 0.0116 0.0515 1
Loa Loa (eye worm) hypothetical protein 0.0161 0.0839 0.0867
Trichomonas vaginalis cGMP-dependent 3,5-cyclic phosphodiesterase, putative 0.0161 0.0839 0.233
Trichomonas vaginalis cAMP-specific phosphodiesterase, putative 0.0161 0.0839 0.233
Trichomonas vaginalis conserved hypothetical protein 0.0116 0.0515 0.1431
Trichomonas vaginalis WD repeat domain, putative 0.0543 0.36 1
Trichomonas vaginalis cAMP/cGMP cyclic nucleotide phosphodiesterase, putative 0.0161 0.0839 0.233
Trichomonas vaginalis retinoblastoma binding protein, putative 0.0071 0.0188 0.0523
Trypanosoma cruzi cAMP specific phosphodiesterase, putative 0.0161 0.0839 1
Loa Loa (eye worm) hypothetical protein 0.0071 0.0188 0.0195
Mycobacterium ulcerans putative regulatory protein 0.0116 0.0515 0.5
Trichomonas vaginalis cAMP-specific phosphodiesterase, putative 0.0161 0.0839 0.233
Trichomonas vaginalis cGMP-specific 3,5-cyclic phosphodiesterase, putative 0.0161 0.0839 0.233
Trichomonas vaginalis high-affinity cGMP-specific 3,5-cyclic phosphodiesterase, putative 0.0161 0.0839 0.233
Mycobacterium tuberculosis Two component sensor histidine kinase DosT 0.0116 0.0515 0.5
Toxoplasma gondii hypothetical protein 0.0116 0.0515 1
Trichomonas vaginalis calcium/calmodulin-dependent 3,5-cyclic nucleotide phosphodiesterase, putative 0.0161 0.0839 0.233
Echinococcus granulosus wd40 repeat 0.0071 0.0188 0.0188
Trichomonas vaginalis cGMP-dependent 3,5-cyclic phosphodiesterase, putative 0.0161 0.0839 0.233
Trichomonas vaginalis calcium/calmodulin-dependent 3,5-cyclic nucleotide phosphodiesterase, putative 0.0161 0.0839 0.233
Trichomonas vaginalis cone cGMP-specific 3,5-cyclic phosphodiesterase, putative 0.0161 0.0839 0.233
Echinococcus granulosus protein will die slowly 0.0543 0.36 0.36
Trichomonas vaginalis cGMP-inhibited 3,5-cyclic phosphodiesterase, putative 0.0161 0.0839 0.233
Trichomonas vaginalis cAMP-specific 3,5-cyclic phosphodiesterase, putative 0.0161 0.0839 0.233
Trichomonas vaginalis cyclic nucleotide phosphodiesterase, putative 0.0161 0.0839 0.233
Mycobacterium tuberculosis Two component sensor histidine kinase DevS 0.0116 0.0515 0.5
Loa Loa (eye worm) hypothetical protein 0.1267 0.8838 0.9133
Echinococcus multilocularis protein will die slowly 0.0543 0.36 0.36
Mycobacterium ulcerans two component sensor histidine kinase DevS 0.0116 0.0515 0.5
Echinococcus multilocularis cAMP and cAMP inhibited cGMP 3',5' cyclic 0.1428 1 1
Brugia malayi Hypothetical WD-repeat protein F21H12.1 in chromosome II 0.0071 0.0188 0.0188
Trichomonas vaginalis cAMP-specific 3,5-cyclic phosphodiesterase, putative 0.0161 0.0839 0.233
Trichomonas vaginalis conserved hypothetical protein 0.0116 0.0515 0.1431
Trichomonas vaginalis conserved hypothetical protein 0.0116 0.0515 0.1431
Schistosoma mansoni retinoblastoma binding protein 0.0071 0.0188 0.0523
Echinococcus granulosus dual 3'5' cyclic AMP and GMP phosphodiesterase 0.0161 0.0839 0.0839
Loa Loa (eye worm) hypothetical protein 0.1383 0.9676 1
Trichomonas vaginalis high-affinity cGMP-specific 3,5-cyclic phosphodiesterase, putative 0.0161 0.0839 0.233
Trichomonas vaginalis cyclic nucleotide phosphodiesterase, putative 0.0161 0.0839 0.233
Loa Loa (eye worm) WD40 repeat protein 0.0543 0.36 0.3721
Trypanosoma brucei cAMP-specific phosphodiesterase 0.0161 0.0839 1
Trichomonas vaginalis cyclic nucleotide phosphodiesterase, putative 0.0161 0.0839 0.233
Toxoplasma gondii GAF domain-containing protein 0.0116 0.0515 1
Trichomonas vaginalis calcium/calmodulin-dependent 3,5-cyclic nucleotide phosphodiesterase, putative 0.0161 0.0839 0.233
Brugia malayi Will die slowly protein 0.0543 0.36 0.36
Trichomonas vaginalis cGMP-specific 3,5-cyclic phosphodiesterase, putative 0.0161 0.0839 0.233
Giardia lamblia Hypothetical protein 0.0045 0 0.5
Trichomonas vaginalis rod cGMP-specific 3,5-cyclic phosphodiesterase, putative 0.0161 0.0839 0.233
Schistosoma mansoni cgmp-dependent 35-cyclic phosphodiesterase 0.0161 0.0839 0.233
Echinococcus multilocularis wd40 repeat 0.0071 0.0188 0.0188
Trichomonas vaginalis high-affinity cGMP-specific 3,5-cyclic phosphodiesterase, putative 0.0161 0.0839 0.233
Trichomonas vaginalis calcium/calmodulin-dependent 3,5-cyclic nucleotide phosphodiesterase, putative 0.0161 0.0839 0.233
Giardia lamblia hypothetical protein 0.0045 0 0.5
Trichomonas vaginalis high-affinity cGMP-specific 3,5-cyclic phosphodiesterase, putative 0.0161 0.0839 0.233
Brugia malayi 3'5'-cyclic nucleotide phosphodiesterase family protein 0.0161 0.0839 0.0839
Trichomonas vaginalis conserved hypothetical protein 0.0071 0.0188 0.0523
Trichomonas vaginalis calcium/calmodulin-dependent 3,5-cyclic nucleotide phosphodiesterase, putative 0.0161 0.0839 0.233
Trichomonas vaginalis cone cGMP-specific 3,5-cyclic phosphodiesterase, putative 0.0161 0.0839 0.233
Schistosoma mansoni hypothetical protein 0.0543 0.36 1
Trichomonas vaginalis conserved hypothetical protein 0.0161 0.0839 0.233
Trichomonas vaginalis high-affinity cGMP-specific 3,5-cyclic phosphodiesterase, putative 0.0161 0.0839 0.233
Trypanosoma brucei cAMP-specific phosphodiesterase 0.0161 0.0839 1

Activities

No activities found for this compound.

Phenotypes

Whole-cell/tissue/organism interactions

We have no records of whole-cell/tissue assays done with this compound What does this mean?

Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.

Annotated phenotypes:

We have no manually annotated phenotypes for this drug. What does this mean? / Care to help?
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
 
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.

External resources for this compound

Bibliographic References

No literature references available for this target.

If you have references for this compound, please enter them in a user comment (below) or Contact us.